|
|
|
|
|
|
|
Entry Options |
|
|
|
|
|
|
|
|
|
Link to related information: |
|
|
Save entry: |
|
|
|
View: |
|
|
|
|
|
|
|
|
|
|
|
CABRI:DSMZ_MUTZ |
Accession_number |
ACC 42
|
Cell_line_name |
697
|
Brief_description |
confirmed as human with IEF of AST, MDH, NP established from the bone marrow of
a 12-year-old boy with acute lymphoblastic leukemia (cALL) at relapse in 1979; cells
express BCL2, BCL3 and MYC mRNA; recently termed "EU-3" in the literature
|
Description |
human B cell precursor leukemia established from the bone marrow of a 12-year-old
boy with acute lymphoblastic leukemia (cALL) at relapse in 1979; cells express BCL2,
BCL3 and MYC mRNA; recently termed "EU-3" in the literature confirmed as human
with IEF of AST, MDH, NP
|
Depositor |
Dr. M. Cooper, University of Alabama, Birmingham, Alabama, USA
|
Morphology |
round, single cells and clusters of cells in suspension
|
Culture_conditions |
80-90% RPMI 1640 + 10-20% FBS cells are difficult to culture; maintain at 0.5-1.5 x
10 6 cells/ml; split saturated culture at 1:3 every 2-3 days; seed out at ca. 1.0 x 106
cells/ml; it is of advantage to start in 24-well-plates at 37C with 5% CO2 maximal
density at about 2-3 x 106 cells/ml
|
Viruses |
ELISA: reverse transcriptase negative; PCR: EBV -, HBV -, HCV -, HHV-8 -, HIV -,
HTLV-I/II -, SMRV -
|
Properties |
CD3 -, CD10 +, CD13 -, CD19 +, CD20 (+), CD34 -, CD37 -, CD38 +, cyCD79a +,
CD80 -, CD138 -, HLA-DR +, cyIgM +, cyIgG -, sm/cykappa -, sm/cylambda -
|
Release_conditions |
-
|
Hazard |
-
|
Storage |
frozen with 70% medium, 20% FBS, 10% DMSO at about 5-8 x 106 cells/ampoule
|
Doubling_time |
about 30-40 hours
|
Mycoplasma |
contamination was eliminated with Mycoplasma Removal Agent, then negative in
|
Fingerprint |
multiplex PCR of minisatellite markers revealed a unique DNA profile
|
Cytogenetics |
human near diploid karyotype - 46(45-48)<2n>XY, t(1;19)(q23;p13), del(6)(q21)
|
Bibliographic_reference |
Findley et al., Blood, 60: 39 (1982) [PMID: 6982733
] |
|